[ad_1]
A new test could pick out women with advanced breast cancer who are likely to benefit from an exciting new targeted...
[ad_1]
When Yelak Biru was diagnosed with stage 3 multiple myeloma in 1995, his prospects looked grim. The antibody-producing immune cells in his bone marrow were growing out of control and had lodged in several of his bones. He was a newly married graduate...
[ad_1]
The University of Maryland School of Medicine (UMSOM), University of Maryland Medical Center (UMMC), and the Tuberous Sclerosis Alliance (TS Alliance) have joined together to launch first-of-a-kind centers in Maryland to treat adults with neurodevelopmental...
[ad_1]
SEQUIM — Some 200 advocates of the Jamestown S’Klallam Tribe’s proposed medicine-assisted treatment clinic were presented with the initial designs for it while dozens of protesters objected a few hundred yards away.
The invitation-only gathering on Thursday evening was conducted in the tribe’s Jamestown...
[ad_1]
07 Dec CAPTIVATE Study: Ibrutinib Plus Venetoclax for First-line Treatment of CLL/SLLMedicalResearch.com Interview with:Prof. TamConstantine Tam, M.D.Hematologist and Disease Group LeadLow Grade Lymphoma and CLL atPeter MacCallum Cancer CentreVictoria, Australia, andLead study investigator of CAPTIVATEMedicalResearch.com: What is the background for this study? Response:...
[ad_1]
When a government team held a “ligation festival” to register women for sterilization in La Legua, Peru, Celia Durand resisted.
The 31-year-old mother of three was appalled at the pressure tactics government health workers used to induce women to have tubal ligations, her husband,...
